Ayawan, Nancy L.

HRN: 01-38-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2022
CEFUROXIME 1.5GM (VIAL)
12/16/2022
12/17/2022
IVT
1.5gms
Prior To OR
Gartner Duct Cyst For Excision Of Vaingal Mass
Waiting Final Action 
12/17/2022
CEFUROXIME 500MG (TAB)
12/17/2022
12/24/2022
PO
500mg
BID X 7 Days
S/P Excision Of Vaginal Mass Under SAB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: